Clinical Trials Committee – 2016 Meeting Dates, Deadlines and Fees

The HREBA – Clinical Trials Committee (CTC) only accepts new submissions through IRISS.  The CTC office must receive all new study applications together with all supporting documents before 4 pm on the submission date.

 Please note: there are no exceptions to the 4 pm submission deadline.

This is the current schedule:

Meeting Date
(3rd Friday of the month except where indicated by *)		 Deadline for Submission
(4th Tuesday prior to meeting except where indicated by *)
15 January 2016 * 15 December 2015
19 February 2016 26 January 2016
18 March 2016 23 February 2016
15 April 2016 22 March 2016
* 13 May 2016 * 19 April 2016
17 June 2016 24 May 2016
15 July 2016 * 21 June 2016
19 August 2016 26 July 2016
16 September 2016 23 August 2016
* 28 October 2016 27 September 2016
18 November 2016 25 October 2016
16 December 2016 22 November 2016

After meeting, the CTC will notify Investigators of the results of the review within one week.

Note: Effective June 15, 2001, in accordance with Section 50(4) of The Health Information Act, the CTC provides to the Information and Privacy Commissioner, copies of approvals granted by the Committee. 

2016 FEES

  IMPORTANT: As of November 1, 2016, all cheques must be payable to “Alberta Innovates”.

The applicable fees listed below are required with the submission of documents for review.  Processing and review will not proceed until the Primary Investigator issues payment to Alberta Innovates.  All fees include the GST.

Full Review: $6190.00

Full Review – Extension Studies & Sub-studies (if submitted simultaneously with original protocol): $1185.00

Expedited Review: $2960.00

Reciprocal Review: $1200.00

Additional Qualified Investigator Review: $590.00

Assessment of Protocol: $615.00

Amendment Review: $1185.00

Annual Review: $340.00

Final Review: $335.00

Waiver of Fees

The CTC may reduce or waive fees for studies being conducted on a smaller financial scale or for which no funding is available.

The relevant fee, however, must be included when submitting the study documents and the Primary Investigator must provide a written request for reduction or waiver of fees to:

Wendy Burrill, Associate Director, Research Ethics
Health Research Ethics Board of Alberta
1500 – 10104 103 Avenue NW
Edmonton, Alberta, T5J 4A7

After review and approval of a request for reduction or waiver of a fee, Alberta Innovates will return/refund the applicable amount.